CL2013003066A1 - Composition for treatment of wounds because it comprises support matrix and stem cells mesenchymics of wharton jelly; method for treating wounds comprising applying said composition - Google Patents
Composition for treatment of wounds because it comprises support matrix and stem cells mesenchymics of wharton jelly; method for treating wounds comprising applying said compositionInfo
- Publication number
- CL2013003066A1 CL2013003066A1 CL2013003066A CL2013003066A CL2013003066A1 CL 2013003066 A1 CL2013003066 A1 CL 2013003066A1 CL 2013003066 A CL2013003066 A CL 2013003066A CL 2013003066 A CL2013003066 A CL 2013003066A CL 2013003066 A1 CL2013003066 A1 CL 2013003066A1
- Authority
- CL
- Chile
- Prior art keywords
- composition
- wounds
- mesenchymics
- treatment
- applying
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
- A61L15/325—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/60—Materials for use in artificial skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/64—Animal cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Hematology (AREA)
- Transplantation (AREA)
- Diabetes (AREA)
- Cell Biology (AREA)
- Vascular Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Developmental Biology & Embryology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Botany (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Materials Engineering (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
LA INVEN´CIÓN PROPORCIONA UNA COMPOSICION PARA TRATAMIENTO DE HERIDAS PORQUE COMPRENDE MATRIZ SOPORTE Y CÉLULAS TRONCALESMESENQUIÁMICAS DE GELATINA DE WHARTON; METODO PARA TRATAR HERIDAS QUE COMPRENDE APLICAR DICHA COMPOSICIONTHE INVENTION PROVIDES A COMPOSITION FOR WOUND TREATMENT BECAUSE IT INCLUDES SUPPORT MATRIX AND TRONCHAL MESENCHIAMIC GELATIN CELLS; METHOD TO TREAT WOUNDS THAT YOU UNDERSTAND TO APPLY SUCH COMPOSITION
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CL2013003066A CL2013003066A1 (en) | 2013-10-22 | 2013-10-22 | Composition for treatment of wounds because it comprises support matrix and stem cells mesenchymics of wharton jelly; method for treating wounds comprising applying said composition |
PCT/CL2014/000055 WO2015058318A1 (en) | 2013-10-22 | 2014-10-20 | Composition for accelerating or improving the healing of wounds, and method for accelerating or improving the healing of wounds, comprising the application of said composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CL2013003066A CL2013003066A1 (en) | 2013-10-22 | 2013-10-22 | Composition for treatment of wounds because it comprises support matrix and stem cells mesenchymics of wharton jelly; method for treating wounds comprising applying said composition |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2013003066A1 true CL2013003066A1 (en) | 2014-07-25 |
Family
ID=52020872
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2013003066A CL2013003066A1 (en) | 2013-10-22 | 2013-10-22 | Composition for treatment of wounds because it comprises support matrix and stem cells mesenchymics of wharton jelly; method for treating wounds comprising applying said composition |
Country Status (2)
Country | Link |
---|---|
CL (1) | CL2013003066A1 (en) |
WO (1) | WO2015058318A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106310369A (en) * | 2016-09-29 | 2017-01-11 | 广州赛莱拉干细胞科技股份有限公司 | Composition, 3D (three-dimensional) dressing with composition and preparation method thereof |
ES2846923T3 (en) * | 2017-09-18 | 2021-07-30 | Banc De Sang I Teixits | Composition to regenerate bone tissue, preparation procedure and use of it |
US10758571B1 (en) * | 2019-04-09 | 2020-09-01 | Combangio, Inc. | Processes for making and using a mesenchymal stem cell derived secretome |
CN111760064A (en) * | 2020-08-25 | 2020-10-13 | 重庆大学附属肿瘤医院 | Dressing for treating diabetic foot and preparation method thereof |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2012205269B2 (en) | 2004-03-22 | 2015-08-27 | Mesoblast International Sarl | Mesenchymal stem cells and uses therefor |
US8709081B2 (en) * | 2006-10-23 | 2014-04-29 | Stemedica Cell Technologies, Inc. | Cellular scaffold |
KR101101321B1 (en) | 2008-11-03 | 2012-01-02 | 주식회사 엠씨티티 | cell delivery vehicle composition having a hydrogel form for healing wounds |
US8652458B2 (en) | 2008-11-25 | 2014-02-18 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Tissue graft with non-aligned fiber matrix retains mesenchymal progenitor cells on the non-injury-facing side |
KR101109125B1 (en) | 2009-03-24 | 2012-02-15 | 한국과학기술연구원 | Method for the differentiation of stem cells into vascular endothelial cells and induction of angiogenesis using the same |
US20120269776A1 (en) * | 2009-08-25 | 2012-10-25 | Miguel Alaminos Mingorance | Productions of artificial tissues by means of tissue engineering using agarose-fibrin biomaterials |
CN102892880A (en) * | 2010-01-14 | 2013-01-23 | 奥加诺吉尼西斯公司 | Bioengineered tissue constructs and methods for producing and using thereof |
ITMI20100601A1 (en) * | 2010-04-09 | 2011-10-10 | Luisa Benassi | "NEW DERMIC SUBSTITUTE AND ITS THERAPEUTIC APPLICATION" |
WO2012131618A1 (en) | 2011-03-30 | 2012-10-04 | Stempeutics Research Private Limited | A composition comprising pooled wharton's jelly derived mesenchymal stem cells and methods thereof |
SG10201701112QA (en) * | 2012-08-15 | 2017-04-27 | Univ Singapore | Wound dressing nanomesh impregnated with human umbilical cord wharton's jelly stem cells |
-
2013
- 2013-10-22 CL CL2013003066A patent/CL2013003066A1/en unknown
-
2014
- 2014-10-20 WO PCT/CL2014/000055 patent/WO2015058318A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2015058318A1 (en) | 2015-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NI201600051A (en) | COMBINATIONS OF HISTONE DESACETILASE INHIBITORS AND IMMUNOMODULATING DRUGS | |
BR112017018234A2 (en) | pd-1 / pd-l1 inhibitors for cancer treatment | |
BR112017018954A2 (en) | Use of Ras Protein Mutant Form and Method to Treat Cancer | |
CL2015002708A1 (en) | Heterocyclic compounds and their uses. | |
CL2015000699A1 (en) | Methods for cancer treatment. | |
BR112017016019A2 (en) | method for cancer treatment, article for manufacture, and kit. | |
CL2015002754A1 (en) | Method for decellularization of tissue grafts | |
CR20160308A (en) | COMBINATIONS OF INHIBITORS OF HISTONA DEACETILASE AND IMMUNOMODULATING PHARMACOS | |
DK2731564T3 (en) | Wound dressing and method of treatment thereof | |
GT201400036A (en) | COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF THE QUINASE C - KIT | |
BR112013017506A2 (en) | wound and skin care devices and methods | |
CL2018001258A1 (en) | Methods for treating conditions associated with activation of the masp-2-dependent complement | |
CR20120413A (en) | DERIVATIVES OF FUMARATE OF FATTY ACID AND ITS USES | |
CL2015002807A1 (en) | Combination therapy | |
BR112015028193B8 (en) | SUPPORT FOR WOUND HEALING | |
CR20140573A (en) | NAMPT INHIBITORS | |
CL2016000326A1 (en) | Compositions and method to treat conditions associated with the complement | |
CL2017002774A1 (en) | Improved uricase sequences and treatment methods | |
BR112013023227A2 (en) | Method for treating loss of circulation, and lost gelling circulation material (lcm) | |
EA201792496A1 (en) | METHODS OF TREATMENT OF INFLAMMATION OR NEUROPATHIC PAIN | |
EP3194013A4 (en) | A wound care bandage and method of wound healing | |
CL2015002723A1 (en) | Methods to treat psoriasis using an anti-il-23 antibody | |
CL2013003066A1 (en) | Composition for treatment of wounds because it comprises support matrix and stem cells mesenchymics of wharton jelly; method for treating wounds comprising applying said composition | |
UY34070A (en) | METHOD AND COMPOSITION FOR SEED TREATMENT. | |
UY37534A (en) | METHOD FOR THE TREATMENT OF FIBROTIC DISEASES USING INTERFERON-LAMBDA |